Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose atropine 0.05% and binocular vision in young adult myopes
ACTRN12621000075886Phase 3Completed
- Sponsor
- Queensland University of Technology
- Start
- Jul 2021
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of atropine in myopia (2 arms), sponsored by Queensland University of Technology. Primary endpoints: Change in near heterophoria, Change in near fusional reserves and 1 more. Started Jul 2021; status: completed.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on ACTRN12621000075886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000075886.